Inhaled Agents Part 2 Flashcards
When is Ether day?
October 16, 1846
WTG Morton successfully demonstrates the use of ether in the removal of a jaw tumor at Mass Gen
Fresh gas flow is determined by
the vaporizer and flowmeter settings
Fractional inspired gas concentration is determined by
FGF rate, breathing-circuit volume and machine absorption
Fractional arterial gas concentration is affected by
ventilation/perfusion mismatching
Fractional alveolar gas concentration is determined by
uptake, ventilation, and the concentration effect and second gas effect
The Fi/FA ratio is a
gas to gas ratio
Factors that affect inspiratory concentration include
fresh gas flow, breathing system volume, & machine absorption
Factors affecting alveolar concentration include
blood solubility of the agent, alveolar blood flow, partial pressure between alveoli and venous blood
If Fa is less than the end-tidal level it is possible that
venous admixture, alveolar dead space, or non-uniform distribution exists
Ventilation/perfusion mismatch can occur in a situation such as
right bronchial intubation
The overall effect for V/Q mismatch is
increase in alveolar partial pressure (highly soluble agents) and decrease in arterial partial pressure (low solubility agents)
What is the mechanism of action of inhaled gases?
unknown
possible targets may include: NMDA receptors, Tandem pore potassium channels, voltage-gated sodium channels, glycine receptors, & GABA receptors
What is the Meyer Overton Theory?
liphophilicity equates to potency
this is not absolute though
What are the CNS effects of inhaled gases?
CMRO2 is decreased
cerebral blood flow is increased (dose-dependent)
What does “uncoupling” mean?
describes the phenomenon of a decrease in CMRO2 but an increase in cerebral blood flow
greater with sevoflurane
What does nitrous oxide do to the brain?
increases both CMRO2 and CBF
mild hyperventilation helps attenuate increases in
CBF
Clinically relevant doses of inhalational agents preserve this when ICP is a concern, mild hyperventilation 30-35 mmHg
cerebral vascular responsiveness to CO2
What is the effect of inhalational agents on evoked potentials?
inhalational agents decrease amplitude and increase latency
EEG and evoked potentials
inhalational agents produce a dose-related suppression
burst suppression occurs at: 1.5 MAC of desflurane & 2 MAC with isoflurane and sevoflurane
For neonates having surgery,
there is a concern for developmental neurotoxicity
it was demonstrated in rodents and non-human primates that they cause activation of extrinsic and intrinsic apoptotic cell death pathways
When giving gas to neonates it is recommended that
keep surgery as short as possible
use short acting medications and multimodal approaches
All volatile inhalation agents reduce
cardiac output and index in a dose-dependent fashion
Volatile agents and nitrous oxide induce HR changes via
SA node antagonism
modulation of baroreflex activity
sympathetic nervous system activity
Reduced MAP secondary to
SVR reduction
nitrous oxide used in combination with anesthetics reduces this
Reduced cardiac output is caused by
reduction in free intracellular Ca2+ contractil state
As MAC hours increase, there is slight increase of CI and HR
Emergence delirium in children
is more common with sevoflurane and desflurane
& can cause injury & delay discharge
Emergence delirium in children can be prevented by
having a quiet, stress-free environment and giving medication adjuncts
Postoperative cognitive dysfunction is of
great concern in the elderly
there is no clinically significant association between major surgery and anesthesia with long-term POCD
Nitrous oxide causes a slight increase in
PVR and it worsens in patients with pulmonary hypertension
The volatile agents affect pulmonary circulation
by decreasing pulmonary artery pressure
Gases are able to affect the pulmonary circulation by
mildly depressing hypoxic pulmonary vasoconstriction
isoflurane has the greatest effect
All inhalational agents produce some
vasodilation (SVR)
in hypotensive patients this can result in a ‘reverse-Robin Hood’ syndrome (isoflurane)
Preconditioning is
a phenomenon in which the heart is exposed to a cascade of intracellular events that protect it from ischemic and reperfusion insult
Sensitization is
when volatile agents reduce the quantity of catecholamines necessary to evoke arrhythmias
Less common in ASA I & II classifications
The CO, SVR, MAP, and HR in isoflurane:
CO: decreased
SVR: decreased
MAP: decreased
HR: increased
The CO, SVR, MAP and HR in desflurane:
CO: —
SVR: decreased
MAP: decreased
HR: increased
The CO, SVR, MAP, and HR in sevoflurane:
CO: –
SVR decreased
MAP: decreased
HR: no change
The CO, SVR, MAP, and HR in nitrous oxide:
CO: decreased
SVR: increased
MAP: no change
HR: increased
The CO, SVR, MAP, and HR in xenon is:
CO: no change
SVR: no change
MAP: no change
HR: decreased